Advances in the treatment of solid tumors in children and adolescents

Tumor is one of the leading causes of death in children (0 to 14‐year‐old) and adolescents (15 to 19‐year‐old) worldwide. Unlike adult tumors, childhood and adolescent tumors are unique in their type, molecular characteristics, and pathogenesis, and their treatment involves many challenges. In recen...

Full description

Saved in:
Bibliographic Details
Published in:Cancer innovation (Print) 2023-04, Vol.2 (2), p.131-139
Main Authors: Tian, Jing, Wang, Jiayu, Li, Sidan
Format: Article
Language:English
Subjects:
Adults
Antigens
Cancer therapies
Chemotherapy
children and adolescents
Clinical trials
Disease control
Drug dosages
immune checkpoint inhibitors
Immunotherapy
Induction therapy
Kinases
Leukemia
Lung cancer
Lymphocytes
Lymphoma
Melanoma
Metastasis
Monoclonal antibodies
Pediatrics
Radiation therapy
Remission (Medicine)
Response rates
Review
Reviews
Rhabdomyosarcoma
Surveillance
Teenagers
treatment
tumor
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tumor is one of the leading causes of death in children (0 to 14‐year‐old) and adolescents (15 to 19‐year‐old) worldwide. Unlike adult tumors, childhood and adolescent tumors are unique in their type, molecular characteristics, and pathogenesis, and their treatment involves many challenges. In recent years, with the development of a large number of clinical studies, the survival rate of children and adolescents with tumors has improved significantly. The extensive research and application of optimized treatment regimens and new targeted drugs have led to new hope for the treatment of childhood and adolescent tumors. This article reviews the clinical and basic research and treatment of childhood and adolescent tumors and provides new ideas for the future development of precise treatment of childhood and adolescent tumors. The tumor is one of the threats to children and adolescents' life and health, causing death and reduced quality of life. But there are few studies on them. Improving the survival rate and survival time of patients is our common goal. We reviewed the literature in recent years, and summarized the new progress achieved in terms of chemotherapy regimens, molecular targeted drugs, and immunotherapy, to provide new ideas for the treatment of tumors in children and adolescents.
ISSN:2770-9183
2770-9191
2770-9183
DOI:10.1002/cai2.66